Primary analysis | |
Adjusting for propensity scores | 0.85 (0.78–0.94) |
Stratified by propensity score quintiles | 0.85 (0.78–0.93) |
Matched analysis | 0.86 (0.79–0.94) |
Secondary analyses | |
Limited to intermediate complexity radiation therapy planning¶ | |
Adjusting for propensity scores | 0.77 (0.69–0.86) |
Stratified by propensity score quintiles | 0.77 (0.69–0.86) |
Matched analysis | 0.78 (0.70–0.87) |
Limited to complex radiation therapy planning | |
Adjusting for propensity scores | 1.03 (0.88–1.12) |
Stratified by propensity score quintiles | 1.00 (0.87–1.14) |
Matched analysis | 1.04 (0.89–1.22) |
Adjusting for time trends | |
Adjusting for propensity scores | 0.88 (0.80–0.96) |
Stratified by propensity score quintiles | 0.87 (0.80–0.95) |
Matched analysis | 0.88 (0.81–0.96) |
Stage I disease treated with intermediate complexity radiation therapy planning | |
Adjusting for propensity scores | 0.80 (0.70–0.90) |
Stratified by propensity score quintiles | 0.80 (0.70–0.91) |
Matched analysis | 0.78 (0.70–0.89) |
Stage I disease treated with complex radiation therapy planning | |
Adjusting for propensity scores | 1.14 (0.95–1.34) |
Stratified by propensity score quintiles | 1.13 (0.94–1.35) |
Matched analysis | 1.08 (0.90–1.29) |
Stage II disease treated with intermediate complexity radiation therapy planning | |
Adjusting for propensity scores | 0.72 (0.58–0.89) |
Stratified by propensity score quintiles | 0.70 (0.57–0.87) |
Matched analysis | 0.66 (0.53–0.82) |
Stage II disease treated with complex radiation therapy planning | |
Adjusting for propensity scores | 0.64 (0.45–0.90) |
Stratified by propensity score quintiles | 0.61 (0.44–0.86) |
Matched analysis | 0.70 (0.48–0.98) |